Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Open-Label, Active-Controlled, Parallel Study to Assess the Efficacy and Safety of Ferric Citrate Capsules for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis

NCT03984760 is registered in ClinicalTrials.gov with Panion & BF Biotech Inc. as lead sponsor.

NCT NCT03984760
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03984760 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Open-Label, Active-Controlled, Parallel Study to Assess the Efficacy and Safety of Ferric Citrate Capsules for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis
Lead sponsor
Panion & BF Biotech Inc.
Phase
Phase 3
Overall status
Completed
Start date
June 19, 2019
Completion date
February 20, 2021
Enrollment
240 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease, esrd, hyperphosphatemia